The forecast data for stomach malignant neoplasms mortality in the UK indicates a downward trend from 5.4 deaths per hundred thousand persons in 2024 to 4.8 by 2028. This represents a year-on-year decline of around 1.9% from 2024 to 2025, 1.9% from 2025 to 2026, 2.0% from 2026 to 2027, and 4.0% from 2027 to 2028. The compound annual growth rate (CAGR) implies an average reduction of approximately 2.9% per year over the forecasted period.
Future trends to watch for include advancements in early detection and treatment methods, which could further accelerate the decline in mortality rates. Additionally, the impact of lifestyle changes and preventive healthcare measures could also significantly influence these trends.
